Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
BELBUCA50.66M34.96%
Xtampza Extended-release (ER)45.81M31.61%
Nucynta Immediate-release (IR)25.96M17.91%
Nucynta Extended-release (ER)19.19M13.24%
Symproic3.3M2.28%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States566.77M100.00%